China SXT Pharmaceuticals, Inc. Gains 26.07%

China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ) shot up at $0.22, a gain of 26.1%. From Wed, Feb 16, 2022, the stock recorded 37.50% Up Days and 44.44% Green Days
The stock spiked on Mon, Feb 28, 2022 at $0.24 with a volume of 28M+.
About China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ)
China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Top 10 Gainers:
- ECMOHO Limited (MOHO:NASDAQ), 56.65%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 39.19%
- Nordstrom, Inc. (JWN:NYSE), 37.82%
- Regulus Therapeutics Inc. (RGLS:NASDAQ), 35.56%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 34.51%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 32.02%
- Arlo Technologies, Inc. (ARLO:NYSE), 28.92%
- Rocky Brands, Inc. (RCKY:NASDAQ), 26.59%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 26.07%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 25.89%